Paperpal Prime Logo

European Heart Journal Open : Impact Factor & More

eISSN: 2752-4191
JournalOpen Access
Recommended pre-submission checks
Powered by Paperpal by Editage

European Heart Journal Open Journal Specifications

Indexed in the following public directories

  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher Oxford University Press
Language English
Article Processing ChargesGBP 1765
Publication Time6
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorEuropean Society of Cardiology
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 6
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in European Heart Journal Open ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in European Heart Journal Open

One-Minute Heart Rate Recovery and Clinical Outcomes in Transthyretin Cardiac Amyloidosis: Incremental Model Fit Beyond Conventional CPET Indices
  • 22 Oct 2026
  • European Heart Journal Open
Sex differences in the diabetes-related risk of incident myocardial infarction and relationship to established CHD risk factors. The Tromsø Study (1979-2016)
  • 21 Oct 2026
  • European Heart Journal Open
Lung ultrasound in ambulatory adults with HFpEF: Association between pulmonary congestion and one-year outcomes
  • 16 Oct 2026
  • European Heart Journal Open
Comparing two distinct costing models for health economics of heart failure within a Swedish population-based cohort
  • 15 Oct 2026
  • European Heart Journal Open
Association between elevated C-reactive protein and mortality, healthcare resource utilization and costs in patients with atherosclerotic cardiovascular disease and/or chronic kidney disease
  • 14 Oct 2026
  • European Heart Journal Open
Comparative Efficacy and Safety of De-escalation, Abbreviation, and Standard Potent P2Y12 Inhibitor–Based Dual Antiplatelet Therapy Strategies After Acute Coronary Syndrome: A Network Meta-Analysis
  • 14 Oct 2026
  • European Heart Journal Open
One-Minute Heart Rate Recovery and Clinical Outcomes in Transthyretin Cardiac Amyloidosis: Incremental Model Fit Beyond Conventional CPET Indices
  • 22 Oct 2026
  • European Heart Journal Open
Sex differences in the diabetes-related risk of incident myocardial infarction and relationship to established CHD risk factors. The Tromsø Study (1979-2016)
  • 21 Oct 2026
  • European Heart Journal Open
Lung ultrasound in ambulatory adults with HFpEF: Association between pulmonary congestion and one-year outcomes
  • 16 Oct 2026
  • European Heart Journal Open
Comparing two distinct costing models for health economics of heart failure within a Swedish population-based cohort
  • 15 Oct 2026
  • European Heart Journal Open
Association between elevated C-reactive protein and mortality, healthcare resource utilization and costs in patients with atherosclerotic cardiovascular disease and/or chronic kidney disease
  • 14 Oct 2026
  • European Heart Journal Open
Comparative Efficacy and Safety of De-escalation, Abbreviation, and Standard Potent P2Y12 Inhibitor–Based Dual Antiplatelet Therapy Strategies After Acute Coronary Syndrome: A Network Meta-Analysis
  • 14 Oct 2026
  • European Heart Journal Open

FAQs on European Heart Journal Open